Clinical Characteristics of Target Organ Damage in Primary Aldosteronism with or without Metabolic Syndrome

Table 2

Target organ damage in PA patients with or without MS.

	Without MS ()	With MS ()	value
Parameters
LAD (mm)			<0.001
LVDd (mm)			0.026
IVST (mm)			<0.001
LVPW (mm)			0.012
IMT (mm)			0.015
Creatinine	56.8 (49.5-67.0)	67.3 (56.2-78.4)	0.018
eGFR (ml/min/1.73m^2)	138.2 (119.8-163.0)	129.0 (111.2-150.1)	0.012
UACR (mg/g)	20.0 (8.6-57.0)	28.3 (12.6-82.4)	0.05
Incidence of organ damage
Hypertensive heart disease (%)	29.7	53.1	<0.001
Coronary heart disease (%)	7.4	12.3	0.17
Cerebrovascular disease (%)	22.9	44.2	<0.001
Chronic kidney disease (%)	37.1	43.3	0.31

Data are expressed as the , median (25th–75th percentiles), or raw numbers. , , and . PA: primary aldosteronism; MS: metabolic syndrome; LAD: left atrial anterior and posterior diameters; LVDd: left ventricular diameters; IVST: interventricular septal thickness; LVPW: left ventricular posterior wall thickness; IMT: intima-media thickness; UACR: urinary albumin to creatinine ratio.